This bill requires New York's public health agency to create an awareness campaign about hormone replacement therapy (HRT) for managing perimenopause and menopause symptoms. The campaign must provide clear, evidence-based information on HRT types, benefits, risks, side effects, and current medical guidelines. It directly affects people experiencing perimenopause or menopause by improving access to accurate health information. The law mandates that campaign materials cover symptom management, health risks, and treatment options as specified in the public health code.
Includes implants, replacement dental prosthetic appliances, crowns and root canals as medically necessary dental care and services for coverage under the Medicaid program if a qualified dentist authorizes the procedures.
This bill requires healthcare providers found guilty of serious misconduct - such as sexual abuse, drug abuse harming patients, or inappropriate prescribing resulting in harm - to provide written disclosure to current and new patients before treatment. The disclosure must detail their disciplinary status, penalties, practice restrictions, and resources for further information. Providers must obtain a signed copy of this disclosure before the first patient visit or treatment. Exceptions apply in emergencies or if a patient is incapacitated and their representative isn’t available. The law applies to probationary orders issued on or after January 1, 2026.
Relates to establishing distinctive "Alzheimer's Awareness" license plates; provides that the funding for such be deposited in the "Alzheimer's disease assistance fund".
This bill establishes the "Sickle Cell Treatment Act" to improve care for sickle cell disease patients in New York. It designates five "centers for excellence" (with two north of Putnam/Orange counties) and ten outpatient treatment centers based on patient populations, providing each center with annual funding ($500,000 for excellence centers, $250,000 for outpatient centers) to support specialized care, research, and equipment. The bill also modifies opioid prescribing rules to exempt sickle cell disease patients from a three-month opioid limit, ensuring they can receive necessary pain management without restrictive barriers. These changes directly affect hospitals designated as centers, sickle cell patients requiring specialized care, and healthcare providers managing chronic pain.
This bill (S 4955) sets new standards for how New York's Medicaid Inspector General audits and reviews payments to healthcare providers. It requires the Inspector General to follow specific protocols when checking claims, cost reports, or payments, including providing providers access to applicable standards before audits begin. Key provisions include mandating detailed explanations in audit reports, considering factors like whether errors were minor clerical mistakes (e.g., transposed codes), and limiting recoupment for isolated errors. The bill directly affects Medicaid providers who receive state medical assistance payments, ensuring audits are transparent, fair, and based on clear, documented procedures.
This bill (S 6551) requires health insurance plans in New York to cover image-guided breast biopsies when recommended by a physician based on nationally recognized clinical guidelines. It directly affects patients seeking breast cancer screening and diagnosis, as well as insurance companies that must now include this specific procedure in mandatory coverage. The bill amends insurance law to explicitly add "image-guided breast biopsies" to the list of covered services alongside mammograms, ultrasounds, and MRI scans. Coverage applies only when the procedure aligns with evidence-based guidelines developed by independent medical organizations. The change takes effect January 1, 2026, for all new or renewed insurance policies.
Directs the commissioner of the office of mental health to promulgate rules and regulations prohibiting any suicide prevention or mental health services hotline operated or sponsored by the state from being automated.
This bill amends New York's insurance law to require health insurers to cover image-guided breast biopsies as part of mandatory breast cancer screening. It directly affects patients seeking breast cancer detection and insurers who must provide this coverage when recommended by a physician following nationally recognized clinical guidelines. The key change adds "image-guided breast biopsies" to the list of covered screening and diagnostic imaging procedures, alongside mammograms and ultrasounds. Coverage applies only when the procedure is recommended by a physician and aligns with evidence-based clinical guidelines. The requirement takes effect January 1, 2026, for new or renewed insurance policies.
Includes implants, replacement dental prosthetic appliances, crowns and root canals as medically necessary dental care and services for coverage under the Medicaid program if a qualified dentist authorizes the procedures.
